Niva Bupa Health Insurance Ltd Q1 FY26 – ₹5,494 Cr GDPI, 14.9 Mn Lives, and Still No Dividend
1. At a Glance
Niva Bupa Health Insurance is that flashy new-age insurer that claims to settle your claims in two hours but has been taking two decades to settle its profits. With a market cap of ₹15,063 Cr, PE of 107, and ROE of 8%, the company is basically the Zomato of insurance: everyone uses it, revenue grows like crazy, but profitability is playing hide-and-seek.
2. Introduction
Back in 2008, when health insurance was a luxury product in India (like air fryers today), Bupa entered the market with Max India as a partner. Fast-forward: Max left, True North PE stepped in, then exited, and now Bupa is back as majority shareholder. This company has changed promoters more often than TV serials change storylines.
Today, Niva Bupa is India’s 3rd largest standalone health insurer (SAHI) with 5.1% market share and is the largest seller on Policybazaar.com. Translation: most of us who Googled “best health insurance” ended up in their lap.
And their scale is serious:
14.9 million active lives insured by FY24-end.
10,426 hospitals in the network (enough to treat half of Delhi NCR simultaneously).
210 branches & 152,436 agents as of June 2024.
But here’s the kicker: Despite growing sales at a 42% CAGR (3 years), Niva Bupa still struggles to show consistent profits. It’s like they’re running marathons every quarter but finishing with a limp.
Question: Do you trust an insurer that sells the most policies online but can’t decide if it’s profitable?
3. Business Model – WTF Do They Even Do?
Unlike LIC which insures your entire family tree and a few goats, Niva Bupa sticks to health insurance only. Their product buffet:
Individual health plans with fancy riders (“Lock the Clock” premium freeze – millennials’ dream).
Group health covers for corporates.
Personal accident & travel insurance (because bad luck doesn’t need a passport).
Revenue Mix:
Retail dominates: 68.5% of Gross Written Premium.
Group insurance & corporate covers fill the rest.
USP gimmicks:
“2 Hours Hospitalization” promise (you’re admitted before your chai cools).
AI-driven onboarding & claims tracking.
Data-driven LTV segmentation so they know who’s a long-term sucker—I mean, customer.
In short: Niva Bupa is selling you peace of mind, then monetising your anxiety via premiums.
4. Financials Overview
Metric
Latest Qtr (Jun’25)
YoY Qtr (Jun’24)
Prev Qtr (Mar’25)
YoY %
QoQ %
Revenue
₹1,371 Cr
₹1,124 Cr
₹1,671 Cr
22.0%
-18.0%
EBITDA
-₹93 Cr
-₹103 Cr
₹251 Cr
10%
-137%
PAT
-₹91 Cr
-₹19 Cr
₹206 Cr
-379%
-144%
EPS (₹)
-0.50
-0.10
1.13
-400%
-144%
Comment: Revenue growth is fine, but PAT fell harder than Sensex after a budget speech. Profit swing from +₹206 Cr to -₹91 Cr in a quarter? That’s not volatility; that’s schizophrenia.
5. Valuation Discussion – Fair Value Range Only
PE Method: FY25 EPS ~₹1.17. At CMP ₹81.6, PE = 69x. Industry avg = 25–40x → Fair value: ₹30 – ₹47.
